Overexpression of BCL-x protein in primary breast cancer is associated with high tumor grade and nodal metastases

Cancer Journal from Scientific American

Volumn 3, Issue 4, 1997, Pages 230-237

  Olopade, Olufunmilayo I ^a   Adeyanju, Moses O ^b   Safa, Ahmad R ^b   Hagos, Fitsum ^b   Mick, Rosemarie ^b   Thompson, Craig B ^b   Recant, Wendy M ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

Apoptosis; BCL x; BCL2; Breast cancer; Drug resistance; TP53

Indexed keywords

APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CARCINOMA; CANCER GRADING; DIAGNOSTIC VALUE; GENE CONTROL; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS; BCL-X PROTEIN; BREAST NEOPLASMS; FEMALE; GENES, BCL-2; GENES, P53; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR CELLS, CULTURED;

EID: 0030805125     PISSN: 10814442     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. American Cancer Society: Cancer Facts & Figures-1995. Atlanta: American Cancer Society, 1995:11.
2. Fisher B, Bauer M, Wickerman DL et al. Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer: an NSABP update. Cancer 1983;52:1551-1557.
3. Harrington EAF, Evan AGI. Oncogenes and cell death. Curr Opin Genet Dev 1994;4:120.
4. Reed JC. BCL2 and the regulation of programmed cell death. J Cell Biol 1994;124:1-6.
5. Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994;78:539.
6. Martin SJ, Green DR. Apoptosis as a goal of cancer therapy. Curr Opin Oncol 1994;5:616-621.
7. Chiou SK, Rao L, White E. Bcl-2 blocks p53 dependent apoptosis. Mol Cell Biol 1994;14:2556-2563.
8. Lowe SW, Ruley HE, Jacks T et al. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993;74:957-967.
9. Rasbridge SA, Gillett CE, Seymour AM et al. The effects of chemotherapy on morphology, cellular proliferation, apoptosis, and oncoprotein expression in primary breast carcinoma. Br J Cancer 1994;70:335-341.
10. Silvestrini R, Veneroni S, Daidone MG et al. The Bcl-2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer in patients. J Natl Cancer Inst 1994; 86:499-504.
11. Leek RD, Kaklamanis L, Pezella F et al. bcl-2 in normal human breast and carcinoma, association with estrogen receptor-positive tumors and in situ cancer. Br J Cancer 1994;69:135-139.
12. Boise LH, Gonzalez-Garcia M, Postema CE et al. bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993;74:597-608.
13. Sato T, Hanada M, Bodrug S et al. Interactions among members of the BCL2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci U S A 1994;91:9238-9242.
14. Oltvai Z, Milliman C, Korsmeyer SJ. BCL2 heterodimerizes in vivo with a conserved homolog, BAX, that accelerates programmed cell death. Cell 1993;74:609-619.
15. Sumantra VN, Ealovega MW, Nunez G et al. Overexpression of bcl-xs sensitizes MCF-2 cells to chemotherapy-induced apoptosis. Cancer Res 1995;55:2507-2510.
16. Minn AJ, Rudin CM, Boise LH et al. Expression of Bcl-xl can confer a multidrug resistance phenotype. Blood 1995;86:1903-1909.
17. Krajewski S, Krajewska M, Shabaik A et al. Immunohistochemical analysis of in vivo patterns of Bcl-x expression. Cancer Res 1994; 54:5501-5507.
18. Wrone-Smith T, Johnson T, Nelson B et al. Discordant expression of Bcl-x and Bcl-2 by keratinocytes in vitro and psoriatic keratinocytes in vivo. Am J Pathol 1995;146:1079-1088.
19. Boise LH, Minn AJ, Noel PJ et al. CD28 costimulation can promote T cell survival by enhancing the expression of BCL-XL. Immunity 1995;3:87-98.
20. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741-748.
21. Thor AD, Moore DH II, Edgerton SM et al. Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers. J Natl Cancer Inst 1992;84:845-855.
22. Krajewska M, Moss SF, Krajewska S et al. Elevated expression of BCLX and reduced Bak in primary colorectal adenocarcinomas. Cancer Res 1996;56:2422-2427.
23. Bargou RC, Danuiel PT, Mapara MY et al. Expression of bcl2 gene family in normal and malignant breast tissue: low bax-a expression in tumor cells correlates with resistance towards apoptosis. Int J Cancer 1995;60:854-859.
24. Harris AL. p53 expression in human breast cancer. Adv Cancer Res 1992;59:69-87.
25. Motoyama N, Wang F, Roth KA et al. Massive cell death of immature hematopoietic cells and neurons in BCLX-deficient mice. Science 1995;267:1506-1510.
26. Krajeski S, Blomquist C, Franssila K et al. Reduced expression of preapoptotic gene Bax is associated with poor response to combination chemotherapy and shorter survival in women with metastatic breast adenocarcinoma. Cancer Res 1995;55:4471-4478.